Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 155

Similar articles for PubMed (Select 23605507)

1.

Inhalation of a dry powder ciprofloxacin formulation in healthy subjects: a phase I study.

Stass H, Nagelschmitz J, Willmann S, Delesen H, Gupta A, Baumann S.

Clin Drug Investig. 2013 Jun;33(6):419-27. doi: 10.1007/s40261-013-0082-0.

2.

Inhaled PYY(3-36) dry-powder formulation for appetite suppression.

Kuehl PJ, Boyden T, Dobry DE, Doyle-Eisele M, Friesen DT, McDonald JD, Murri BG, Vodak DT, Lyon DK.

Drug Dev Ind Pharm. 2015 May 26:1-7. [Epub ahead of print]

PMID:
26006332
3.

Characterization of a New High-Dose Dry Powder Inhaler (DPI) Based on a Fluidized Bed Design.

Farkas DR, Hindle M, Longest PW.

Ann Biomed Eng. 2015 May 19. [Epub ahead of print]

PMID:
25986955
4.

First-In-Human, Double-Blind, Placebo-Controlled, Randomized, Dose-Escalation Study of BG00010, a Glial Cell Line-Derived Neurotrophic Factor Family Member, in Subjects with Unilateral Sciatica.

Rolan PE, O'Neill G, Versage E, Rana J, Tang Y, Galluppi G, Aycardi E.

PLoS One. 2015 May 11;10(5):e0125034. doi: 10.1371/journal.pone.0125034. eCollection 2015.

5.

Pulmonary Delivery of Vancomycin Dry Powder Aerosol to Intubated Rabbits.

Sullivan BP, El-Gendy N, Kuehl C, Berkland C.

Mol Pharm. 2015 May 6. [Epub ahead of print]

PMID:
25915095
6.

Pharmacokinetics of sugammadex 16 mg/kg in healthy Chinese volunteers.

de Kam PJ, Hou J, Wang Z, Lin WH, van den Heuvel M.

Int J Clin Pharmacol Ther. 2015 Jun;53(6):456-61. doi: 10.5414/CP202234.

PMID:
25907172
7.

Erratum to: Tolerability of High-Volume Subcutaneous Injections of a Viscous Placebo Buffer: A Randomized, Crossover Study in Healthy Subjects.

Dias C, Abosaleem B, Crispino C, Gao B, Shaywitz A.

AAPS PharmSciTech. 2015 Apr 23. [Epub ahead of print] No abstract available.

PMID:
25904027
8.
9.

A novel inhaled multi-pronged attack against respiratory bacteria.

Lee SH, Teo J, Heng D, Zhao Y, Ng WK, Chan HK, Tan LT, Tan RB.

Eur J Pharm Sci. 2015 Apr 5;70:37-44. doi: 10.1016/j.ejps.2015.01.005. Epub 2015 Jan 19.

PMID:
25612805
10.

Murine pharmacokinetics of rifapentine delivered as an inhalable dry powder.

Chan JG, Tyne AS, Pang A, McLachlan AJ, Perera V, Chan JC, Britton WJ, Chan HK, Duke CC, Young PM, Traini D.

Int J Antimicrob Agents. 2015 Mar;45(3):319-23. doi: 10.1016/j.ijantimicag.2014.11.009. Epub 2014 Dec 16.

PMID:
25554469
11.

Ease-of-use preference for the ELLIPTA® dry powder inhaler over a commonly used single-dose capsule dry powder inhaler by inhalation device-naïve Japanese volunteers aged 40 years or older.

Komase Y, Asako A, Kobayashi A, Sharma R.

Int J Chron Obstruct Pulmon Dis. 2014 Dec 11;9:1365-75. doi: 10.2147/COPD.S72762. eCollection 2014.

12.

First human study of a chimeric anti-methamphetamine monoclonal antibody in healthy volunteers.

Stevens MW, Henry RL, Owens SM, Schutz R, Gentry WB.

MAbs. 2014;6(6):1649-56. doi: 10.4161/19420862.2014.976431.

PMID:
25484042
13.

The safety of ethambutol dihydrochloride dry powder formulations containing chitosan for the possibility of treating lung tuberculosis.

Ahmad MI, Nakpheng T, Srichana T.

Inhal Toxicol. 2014 Dec;26(14):908-17. doi: 10.3109/08958378.2014.975875.

PMID:
25472479
14.

Inhaled anti-infective chemotherapy for respiratory tract infections: Successes, challenges and the road ahead.

Velkov T, Abdul Rahim N, Zhou QT, Chan HK, Li J.

Adv Drug Deliv Rev. 2015 May;85:65-82. doi: 10.1016/j.addr.2014.11.004. Epub 2014 Nov 12. Review.

PMID:
25446140
15.

Pharmacokinetics, pharmacodynamics, safety, and tolerability of nebulized sodium nitrite (AIR001) following repeat-dose inhalation in healthy subjects.

Rix PJ, Vick A, Attkins NJ, Barker GE, Bott AW, Alcorn H Jr, Gladwin MT, Shiva S, Bradley S, Hussaini A, Hoye WL, Parsley EL, Masamune H.

Clin Pharmacokinet. 2015 Mar;54(3):261-72. doi: 10.1007/s40262-014-0201-y.

16.

Correlation of elimination fraction area under the curve with total body clearance.

Grabowski T, Raczyńska-Pawelec A, Starościak M, Jaroszewski JJ.

Eur J Drug Metab Pharmacokinet. 2014 Oct 14. [Epub ahead of print]

PMID:
25312019
17.

Investigating the relationship between peak inspiratory flow rate and volume of inhalation from a Diskus™ Inhaler and baseline spirometric parameters: a cross-sectional study.

Seheult JN, Costello S, Tee KC, Bholah T, Al Bannai H, Sulaiman I, Costello RW.

Springerplus. 2014 Sep 2;3:496. doi: 10.1186/2193-1801-3-496. eCollection 2014.

18.

[Dynamic characteristics of flow trainer for dpi and its clinical relevance].

Kondo T, Shimizu T, Tanigaki T, Hibino M, Ohe M, Tajiri S.

Arerugi. 2014 Sep;63(8):1126-31. Japanese.

PMID:
25273642
20.

Dry powder formulation of simvastatin.

Tulbah AS, Ong HX, Morgan L, Colombo P, Young PM, Traini D.

Expert Opin Drug Deliv. 2015 Jun;12(6):857-68. doi: 10.1517/17425247.2015.963054. Epub 2014 Sep 22.

PMID:
25244365
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk